SBMFF and 1177:HK Related Headlines
Go Back- Sino Biopharmaceutical Ltd. (1177:HK) (SBMFF) PT Lowered to HK$8.50 at Macquarie
- Sino Biopharmaceutical Ltd. (1177:HK) (SBMFF) PT Lowered to HK$9 at HSBC
- Sino Biopharmaceutical Ltd. (1177:HK) (SBMFF) PT Lowered to HK$8.67 at Nomura/Instinet
- UBS Reiterates Buy Rating on Sino Biopharmaceutical Ltd. (1177:HK) (SBMFF)
- Sino Biopharmaceutical Ltd. (1177:HK) (SBMFF) PT Raised to HK$9.80 at Macquarie
- Sino Biopharmaceutical Ltd. (1177:HK) (SBMFF) PT Raised to HK$10.80 at Citi
- Sino Biopharmaceutical Ltd. (1177:HK) (SBMFF) PT Raised to HK$9.17 at Nomura/Instinet
- Sino Biopharmaceutical Ltd. (1177:HK) (SBMFF) PT Raised to HK$8.80 at Citi
- Sino Biopharmaceutical Ltd. (1177:HK) (SBMFF) PT Raised to HK$9.20 at CLSA
- Sino Biopharmaceutical Ltd. (1177:HK) (SBMFF) PT Raised to HK$7.69 at Nomura/Instinet
- Sino Biopharmaceutical Ltd. (1177:HK) (SBMFF) PT Raised to HK$6.19 at Goldman Sachs

